US FDA Approves ChemoCentryx Drug to Treat Rare Autoimmune Disease

(AP Photo/Jacquelyn Martin, File)

Friday, 08 October 2021 07:17 AM EDT ET

The U.S. Food and Drug Administration on Friday approved ChemoCentryx Inc's lead drug candidate, Avacopan, for treating a rare, fatal autoimmune disease, the biopharmaceutical company said.

© 2026 Thomson/Reuters. All rights reserved.


FDA-Approved-Drugs
The U.S. Food and Drug Administration on Friday approved ChemoCentryx Inc's lead drug candidate, Avacopan, for treating a rare, fatal autoimmune disease.
fda, drug, avacopan
26
2021-17-08
Friday, 08 October 2021 07:17 AM
Newsmax Media, Inc.
Newsmax Media, Inc.

View on Newsmax